Skip to main content
Article thumbnail
Location of Repository

Myc Prevents Apoptosis and Enhances Endoreduplication Induced by Paclitaxel

By Giuliana Gatti, Giovanna Maresca, Manuela Natoli, Fulvio Florenzano, Angelo Nicolin, Armando Felsani and Igea D'Agnano
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2006). A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest.
    2. (1999). Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-myc.
    3. (2004). Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.
    4. (2004). Bim is a suppressor of Mycinduced mouse B cell leukemia.
    5. (2001). BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
    6. (2003). c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells.
    7. (1998). c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    8. (2007). c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability.
    9. (2006). c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.
    10. (2001). c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.
    11. (2006). c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells.
    12. (2002). c-Myc functionally cooperates with Bax to induce apoptosis.
    13. (1999). c-Myc overexpression uncouples DNA replication from mitosis.
    14. (1999). c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.
    15. (2006). c-Myc, genome instability, and tumorigenesis: the devil is in the details.
    16. (2002). c-MYC: more than just a matter of life and death.
    17. (1997). Cossarizza A
    18. (2000). Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt’s lymphoma.
    19. (1999). Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    20. (2008). Downregulation of c-Myc determines sensitivity to 2-methoxyestradiol-induced apoptosis in human acute myeloid leukemia.
    21. (2004). Dynamics of cancer progression.
    22. (1994). Effects of c-myc expression on cell cycle progression.
    23. (2005). Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification.
    24. (2007). Felsani A
    25. (2000). Genetic dissection of c-myc apoptotic pathways.
    26. (2005). Genetic instability in cancer: theory and experiment.
    27. (1992). Induction of apoptosis in fibroblasts by c-myc protein.
    28. (1993). Kimchi A
    29. (2005). Knockdown of cMyc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo.
    30. (2003). Microtubule nucleation.
    31. (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of
    32. (2008). Module map of stem cell genes guides creation of epithelial cancer stem cells.
    33. (1998). Myc and the cell cycle.
    34. (2001). Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
    35. (2005). Myc downregulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    36. (1996). Myc oncogenes: the enigmatic family.
    37. (2003). Myc pathways provoking cell suicide and cancer.
    38. (1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
    39. (2003). Mycmediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
    40. (2007). Non-transcriptional control of DNA replication by c-Myc.
    41. (2000). Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts.
    42. (2009). p53 represses c-Myc through induction of the tumor suppressor miR-145.
    43. (2004). Recycling the cell cycle: cyclins revisited.
    44. (2008). Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells.
    45. (2003). Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action.
    46. (2007). The ever expanding role for c-Myc in promoting genomic instability.
    47. (1995). The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro.
    48. (2004). The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation.
    49. (2005). Transcriptional regulation and transformation by Myc proteins.
    50. (1994). Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.